As companies and markets increasingly view patents not just as a defensive shield but as strategic assets (e.g., for licensing, enforcement, or ...
The Trump administration’s recent threat to exercise the Bayh-Dole Act’s march-in rights against Harvard University ...
Federal Circuit Sees Logic in Allowing Expert Testimony on Ordinary Observers in Design Patent Cases
Today, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Smartrend Manufacturing Group (SMG ...
Since the start of 2025, the new USPTO administration has been reshaping trial proceedings at the Patent Trial and Appeal Board ...
A company’s intellectual property (IP) is often its most important asset. In order to better understand how the business ...
According to Russia’s TASS news agency, the Second International Conference “Science for Public Administration in Russia” was ...
Many single asset real estate (SARE) bankruptcies will check some or all of the boxes for a bad faith filing. Nevertheless, ...
The United States is distinctive in many ways, but at least one unique characteristic may change in the coming months. We are one of just two countries in the world that permits prescription drug ...
LittleTechGirl on MSN
Women Breaking Barriers and Setting New Standards
Across industries, women continue to challenge expectations and open doors for those who follow. These leaders are bre ...
Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
A wrongful conviction trial that was expected to conclude Thursday will spill into next week after the plaintiff’s attorney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback